Welcome to Cyberonics
NASDAQ: CYBX) pioneered the Vagus Nerve Stimulation (VNS Therapy) System. Founded in 1987 to design, develop and market implantable medical devices for the treatment of epilepsy, Cyberonics has emerged as a leader in the neuromodulation industry.
The remarkable success of VNS Therapy in the treatment of epilepsy has served as a platform for continued innovation. On July 15, 2005, after seven years of extensive study and clinical trials, VNS Therapy was approved by the FDA as a long-term adjunctive treatment for treatment-resistant depression.
Cyberonics is committed to advancing the treatment of epilepsy through new technologies.
Headquartered in Houston, Texas, Cyberonics also has an office in Brussels, Belgium. The VNS Therapy system is approved for distribution in more than 70 countries worldwide.
